Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579371 · ClinicalTrials.gov registry record · Phase 1
Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus
A Phase 1 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00579371 is a Phase 1 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 30 participants.
The verdict
NCT00579371, a Phase 1 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
We hypothesize that the following improvements to islet transplantation will increase the islet mass successfully isolated and allow for engraftment from a single pancreas. The improvements are: * Using Two-Layer method preservation to improve pancreas quality before islet isolation * Maintaining isolated islets in culture before transplantation * Using a steroid-free immunosuppression regimen * Transplanting the best combination of donor and recipient possible after human leukocyte antigens (HLA) screening and final crossmatching
Interventions
- DRUG Islets of Langerhans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-03-17 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579371
The ClinicalTrials.gov registry entry for NCT00579371 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Islets of Langerhans is the first listed.
NCT00579371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579371 about?
NCT00579371 is a clinical study titled "Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus". We hypothesize that the following improvements to islet transplantation will increase the islet mass successfully isolated and allow for engraftment from a single pancreas. The improvements are: * Using Two-Layer method preservation to improve pancreas quality before islet isolation * Maintaining i...
What is the current status of trial NCT00579371?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2004-03-17. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00579371?
The interventions under investigation include: Islets of Langerhans (DRUG).
Who is sponsoring clinical trial NCT00579371?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.